BCMA is actively cleaved from the surface of multiple myeloma cells by the gamma secretase complex which results in reduced target density and could potentially lead to decreased recognition and anti-BCMA CAR T-cell activity. The gene discussed is TNFRSF17; the disease is AL amyloidosis.